Loop Diuterics: What Effect Do WE Expect from Different Doses and Various Forms of Release?

Authors

  • D.D. Ivanov

DOI:

https://doi.org/10.22141/2307-1257.0.2.2012.176625

Abstract

No abstract

Downloads

Download data is not yet available.

References

http://www.kdigo.org/clinical_practice_guidelines/AKI.php; переклад на сторінці http://nephrology.kiev.ua

Трифас — новый петлевой диуретик в Украине // Медицина сегодня. — 2006. — № 5. — С. 8.

Effects of Prolonged-Release Torase-mide Versus Furosemide on Myocardial Fibrosis in Hypertensive Patients with Chronic Heart Failure: A Randomized, Blinded-End Point, Active-Controlled Study / The TORAFIC Investigators Group Clinical Therapeutics. — 2011. Sept. — Vol. 33, Is. 9. — P. 1204-1213.e3.

Roca-Cusachs A., Aracil-Vilar J., Calvo-Gоmez C. et al. and the Torasemide-PR in Hypertension Clinical Trial Investigators Group. Clinical Effects of Torasemide Prolonged Release in Mild-to-Moderate Hypertension: A Randomized Noninferiority Trial Versus Torasemide Immediate Release // Cardiovascular Therapeutics. — 2008. — 26. — 91-100.

Downloads

Published

2022-02-15

How to Cite

Ivanov, D. (2022). Loop Diuterics: What Effect Do WE Expect from Different Doses and Various Forms of Release?. KIDNEYS, (2), 50–52. https://doi.org/10.22141/2307-1257.0.2.2012.176625

Issue

No. 2 (2012)

Section

Pharmacology Workshop

License

Copyright (c) 2012 D.D. Ivanov

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.